Observational studyClinical and translational science2021

Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study.

Matt K Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.